Cantillon Capital Management Llc increased its stake in Intel Corp (INTC) by 69.74% based on its latest 2018Q3 regulatory filing with the SEC. Cantillon Capital Management Llc bought 1.71M shares as the company’s stock rose 1.97% while stock markets declined. The hedge fund held 4.16M shares of the semiconductors company at the end of 2018Q3, valued at $196.67M, up from 2.45M at the end of the previous reported quarter. Cantillon Capital Management Llc who had been investing in Intel Corp for a number of months, seems to be bullish on the $220.30B market cap company. The stock increased 0.29% or $0.14 during the last trading session, reaching $48.27. About 7.39 million shares traded. Intel Corporation (NASDAQ:INTC) has risen 9.59% since January 17, 2018 and is uptrending. It has outperformed by 9.59% the S&P500. Some Historical INTC News: 17/04/2018 – Ionic Delivers Preview Release Of Secure Files Hardened With Intel® Data Guard At RSA Conference; 15/05/2018 – l-COM 2018: Ekimetrics won the Intel challenge hackathon final showcasing its consultants’ excellence in Data Science; 30/05/2018 – Mapbox partners Microsoft, Intel to provide self-driving car maps; 03/04/2018 – Akamai Appoints Scott Lovett As Senior Vice President, Global Web Sales; 09/05/2018 – AMAZON.COM INC WAS NOT ON ANY WINNING APPLICATIONS FOR U.S. DRONE PILOT PROGRAM – STATEMENT; 02/04/2018 – Intel extends slump on Apple chip report; 29/03/2018 – Schneider Electric Receives Supplier Achievement Award from Strategic Partner, Intel; 26/04/2018 – Intel CEO Brian Krzanich dismissed investor concerns that functionality issues were causing 10-nanometer production delays; 07/03/2018 – DEADLINE ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Intel Corporation (INTC) & Lead Plaintiff Deadline: March 12, 2018; 25/05/2018 – U.S. Equal Employment Opportunity Commission Investigating Age-Discrimination Claims Against Intel
British Columbia Investment Management Corp increased its stake in United Therapeutics Corp Del (UTHR) by 52.11% based on its latest 2018Q3 regulatory filing with the SEC. British Columbia Investment Management Corp bought 16,019 shares as the company’s stock declined 10.66% with the market. The institutional investor held 46,758 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $5.98M, up from 30,739 at the end of the previous reported quarter. British Columbia Investment Management Corp who had been investing in United Therapeutics Corp Del for a number of months, seems to be bullish on the $4.94B market cap company. The stock decreased 0.24% or $0.28 during the last trading session, reaching $113.35. About 100,047 shares traded. United Therapeutics Corporation (NASDAQ:UTHR) has declined 20.84% since January 17, 2018 and is downtrending. It has underperformed by 20.84% the S&P500. Some Historical UTHR News: 07/05/2018 – The Law Offices of Vincent Wong Notifies Investors of an Investigation into SteadyMed Ltd. in Connection with the Sale of the Company to United Therapeutics Corporation — STDY; 30/04/2018 – United Therapeutics to Acquire SteadyMed Ltd; 02/05/2018 – United Therapeutics 1Q EPS $5.57; 30/04/2018 – United Therapeutics To Acquire SteadyMed Ltd. STDY; 27/04/2018 – UNITED THERAPEUTICS SAYS CEO MARTINE ROTHBLATT’S FY 2017 TOTAL COMPENSATION WAS $37.1 MLN WHICH INCLUDED $33.1 MLN IN OPTION/STAP AWARDS – SEC FILING; 30/04/2018 – United Therapeutics to Pay Additional $2.63/Share Upon Achievement of Milestone; 30/04/2018 – UNITED THERAPEUTICS TO BUY STEADYMED FOR $4.46/SHR IN CASH; 30/04/2018 – United Therapeutics: Milestone Related to Commercialization of Trevyent; 02/05/2018 – United Therapeutics 1Q Adj EPS $3.76; 02/05/2018 – UNITED THERAPEUTICS 1Q ADJ. EPS 3.76, EST. $3.56
Since July 25, 2018, it had 2 insider buys, and 7 insider sales for $723,730 activity. On Tuesday, October 30 the insider McBride Kevin Thomas sold $295,945. SWAN ROBERT HOLMES also bought $245,993 worth of Intel Corporation (NASDAQ:INTC) shares. Rodgers Steven Ralph had sold 2,213 shares worth $116,028.
Cantillon Capital Management Llc, which manages about $12.49B and $8.89B US Long portfolio, decreased its stake in Intercontinental Exchange In (NYSE:ICE) by 313,087 shares to 4.65 million shares, valued at $348.26 million in 2018Q3, according to the filing. It also reduced its holding in Verisign Inc (NASDAQ:VRSN) by 78,191 shares in the quarter, leaving it with 1.11M shares, and cut its stake in Facebook Inc (NASDAQ:FB).
Among 57 analysts covering Intel Corporation (NASDAQ:INTC), 33 have Buy rating, 7 Sell and 17 Hold. Therefore 58% are positive. Intel Corporation had 303 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Buy” rating by Robert W. Baird on Monday, September 4. On Friday, July 27 the stock rating was maintained by KeyBanc Capital Markets with “Overweight”. As per Friday, January 15, the company rating was maintained by UBS. B. Riley & Co maintained Intel Corporation (NASDAQ:INTC) on Wednesday, October 19 with “Buy” rating. Citigroup maintained it with “Neutral” rating and $35 target in Thursday, July 21 report. Rosenblatt maintained the stock with “Sell” rating in Wednesday, January 3 report. Citigroup maintained Intel Corporation (NASDAQ:INTC) rating on Tuesday, April 24. Citigroup has “Buy” rating and $60 target. The firm earned “Buy” rating on Thursday, April 7 by Brean Capital. The stock has “Buy” rating by Needham on Wednesday, December 30. As per Tuesday, October 18, the company rating was upgraded by Barclays Capital.
More notable recent Intel Corporation (NASDAQ:INTC) news were published by: Streetinsider.com which released: “Apple (AAPL), Intel (INTC) Can Challenge Validity of Qualcomm (QCOM) Patents – Bloomberg – StreetInsider.com” on January 15, 2019, also Nasdaq.com with their article: “This Intel Product Stood Out in 2018 – Nasdaq” published on December 26, 2018, Nasdaq.com published: “After Hours Most Active for Dec 24, 2018 : S, QQQ, SQQQ, KGC, PLNT, PFE, BAC, MU, QSR, INTC, IEF, SLM – Nasdaq” on December 24, 2018. More interesting news about Intel Corporation (NASDAQ:INTC) were released by: Nasdaq.com and their article: “After Hours Most Active for Dec 27, 2018 : PENN, QQQ, ZNGA, RFP, PFE, MGM, T, ACB, TWTR, IQ, INTC, HOLX – Nasdaq” published on December 27, 2018 as well as Investorplace.com‘s news article titled: “3 Cheap Stocks to Buy (Before They Skyrocket) – Investorplace.com” with publication date: January 16, 2019.
Investors sentiment increased to 0.85 in Q3 2018. Its up 0.04, from 0.81 in 2018Q2. It is positive, as 62 investors sold INTC shares while 728 reduced holdings. 113 funds opened positions while 557 raised stakes. 2.86 billion shares or 2.41% less from 2.93 billion shares in 2018Q2 were reported. Birch Hill Advsr Ltd Liability Corporation reported 193,917 shares stake. Plancorp Llc owns 6,064 shares for 0.11% of their portfolio. Moreover, Becker Cap has 0.81% invested in Intel Corporation (NASDAQ:INTC). Camarda Finance Advisors Lc reported 2,590 shares. Farmers Communication accumulated 138,678 shares or 1.85% of the stock. North Star Investment holds 0.86% of its portfolio in Intel Corporation (NASDAQ:INTC) for 162,804 shares. Usca Ria Limited Liability Company owns 191,579 shares or 0.92% of their US portfolio. Carlton Hofferkamp And Jenks Wealth Mngmt Llc has 0.54% invested in Intel Corporation (NASDAQ:INTC) for 18,670 shares. Ny State Teachers Retirement System reported 7.60M shares. Jlb And Assocs Inc holds 32,471 shares. Accredited Investors reported 0.21% in Intel Corporation (NASDAQ:INTC). Park National Corp Oh reported 884,328 shares stake. Gofen Glossberg Il accumulated 136,541 shares. Hengehold Mgmt Ltd Liability holds 0.72% of its portfolio in Intel Corporation (NASDAQ:INTC) for 60,276 shares. Adell Harriman & Carpenter holds 0% or 144,923 shares.
British Columbia Investment Management Corp, which manages about $9.45 billion US Long portfolio, decreased its stake in Johnson Ctls Intl Plc by 104,585 shares to 286,553 shares, valued at $10.03M in 2018Q3, according to the filing. It also reduced its holding in Lam Research Corp (NASDAQ:LRCX) by 25,703 shares in the quarter, leaving it with 54,545 shares, and cut its stake in Stanley Black & Decker Inc (NYSE:SWK).
More notable recent United Therapeutics Corporation (NASDAQ:UTHR) news were published by: Fool.com which released: “Is MannKind Corporation Stock a Buy? – Motley Fool” on September 08, 2018, also Globenewswire.com with their article: “SteadyMed Shareholders Approve Proposed Acquisition by United Therapeutics – GlobeNewswire” published on July 31, 2018, Fool.com published: “My Top 3 Favorite Clinical-Stage Biotech Stocks to Buy – The Motley Fool” on November 17, 2018. More interesting news about United Therapeutics Corporation (NASDAQ:UTHR) were released by: Seekingalpha.com and their article: “CollPlant and United Therapeutics ink deal for 3D bioprinting of solid-organ scaffolds for human transplants; CLGN up 37% premarket – Seeking Alpha” published on October 22, 2018 as well as Seekingalpha.com‘s news article titled: “Can United Therapeutics’ Patents Fend Off Liquidia And MannKind? – Seeking Alpha” with publication date: June 13, 2018.
Investors sentiment decreased to 1.02 in Q3 2018. Its down 0.21, from 1.23 in 2018Q2. It dropped, as 29 investors sold UTHR shares while 101 reduced holdings. 42 funds opened positions while 91 raised stakes. 40.30 million shares or 1.31% more from 39.78 million shares in 2018Q2 were reported. Macquarie Ltd has 11,800 shares. Lingohr Partner Asset Gmbh has 10,183 shares. Nuwave Inv Mgmt Ltd Com holds 7 shares or 0% of its portfolio. 8,671 were accumulated by Liberty Mutual Gp Asset Management Inc. Guggenheim Ltd Liability Com holds 0.05% in United Therapeutics Corporation (NASDAQ:UTHR) or 57,900 shares. Ing Groep Nv owns 6,660 shares. Arizona State Retirement System accumulated 0.04% or 30,932 shares. Hall Laurie J Trustee, Massachusetts-based fund reported 150 shares. Amp Capital Invsts Limited accumulated 62,465 shares or 0.04% of the stock. Bridgewater Assocs Lp accumulated 53,726 shares. Selway Asset Mgmt invested in 2,075 shares. Rhumbline Advisers owns 79,213 shares for 0.02% of their portfolio. Kbc Grp Nv invested 0.01% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR). Tower Rech Cap Ltd (Trc) stated it has 0.04% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR). Nomura Asset Mngmt Limited owns 6,038 shares or 0.01% of their US portfolio.